Trials / Completed
CompletedNCT00196287
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (planned)
- Sponsor
- Deutsches Herzzentrum Muenchen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.
Conditions
Timeline
- Start date
- 1995-01-01
- First posted
- 2005-09-20
- Last updated
- 2018-03-12
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00196287. Inclusion in this directory is not an endorsement.